Moffitt logo

Clinical Trials Search

Clinical Trial 19619

Cancer Type: Thoracic
Interventions:AZD9291 (Osimertinib); G1T38; Osimertinib

Study Type: Treatment
Phase of Study: Phase I/II
Investigators:

  • Jhanelle Gray

Call 813-745-6100
or 1-800-679-0775
Overview

Study Title

Phase 1b/2 Safety, Pharmacokinetic, and Efficacy Study of G1T38 in Combination with Osimertinib in Patients with EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer (NSCLC)

Summary

Objective